Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression
<b>Background:</b> A valuable outcome measure to monitor amyotrophic lateral sclerosis (ALS) disease progression is crucial in clinical trials. Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) is a novel questionnaire assessing ALS disability. Currently, there a...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589009965023232 |
|---|---|
| author | Can Sun Yong Chen Lu Xu Wenjing Wang Nan Zhang Christina N. Fournier Nan Li Dongsheng Fan |
| author_facet | Can Sun Yong Chen Lu Xu Wenjing Wang Nan Zhang Christina N. Fournier Nan Li Dongsheng Fan |
| author_sort | Can Sun |
| collection | DOAJ |
| description | <b>Background:</b> A valuable outcome measure to monitor amyotrophic lateral sclerosis (ALS) disease progression is crucial in clinical trials. Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) is a novel questionnaire assessing ALS disability. Currently, there are no studies on the relationship between ROADS and ALS survival. This study explored the value of Chinese ROADS as a novel tool for measuring disease progression and the correlation between ROADS and ALS survival. <b>Methods:</b> A total of 170 ALS participants were included in this study. Clinical characteristics and baseline ROADS, ΔROADS, ALSFRS-R, and ΔFRS of patients were collected. Participants were followed for 18 months to assess time to tracheostomy and survival. Scales were collected every 3 to 6 months. We evaluated the association of baseline ROADS and ΔROADS with survival using Cox regression analyses. Linear mixed effects models were used to assess changes over time in ROADS and ALSFRS-R. <b>Results:</b> Multivariate Cox models confirmed that baseline ROADS positively correlated with ALS survival (HR = 0.95, <i>p</i> < 0.001), while baseline ΔROADS negatively correlated with survival (HR = 1.26, <i>p</i> < 0.001). Additionally, linear mixed effects models suggested that ROADS, similar to ALSFRS-R, declined significantly over time, but there was no significant difference between these two. <b>Conclusions:</b> Our study indicates that Chinese ROADS is strongly related to ALS survival. Changes in ROADS with disease progression are similar to those in ALSFRS-R. These findings support Chinese ROADS as a reliable outcome measure for clinical trials, potentially enhancing the dimension of evaluating treatment effectiveness in ALS trials. |
| format | Article |
| id | doaj-art-d106ca6dd0f04b65b1c792d6691b0c56 |
| institution | Kabale University |
| issn | 2227-9059 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj-art-d106ca6dd0f04b65b1c792d6691b0c562025-01-24T13:24:17ZengMDPI AGBiomedicines2227-90592025-01-0113117810.3390/biomedicines13010178Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease ProgressionCan Sun0Yong Chen1Lu Xu2Wenjing Wang3Nan Zhang4Christina N. Fournier5Nan Li6Dongsheng Fan7Department of Neurology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Neurology, Peking University Third Hospital, Beijing 100191, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Neurology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Neurology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Neurology, Emory University, Atlanta, GA 30322, USAResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Neurology, Peking University Third Hospital, Beijing 100191, China<b>Background:</b> A valuable outcome measure to monitor amyotrophic lateral sclerosis (ALS) disease progression is crucial in clinical trials. Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) is a novel questionnaire assessing ALS disability. Currently, there are no studies on the relationship between ROADS and ALS survival. This study explored the value of Chinese ROADS as a novel tool for measuring disease progression and the correlation between ROADS and ALS survival. <b>Methods:</b> A total of 170 ALS participants were included in this study. Clinical characteristics and baseline ROADS, ΔROADS, ALSFRS-R, and ΔFRS of patients were collected. Participants were followed for 18 months to assess time to tracheostomy and survival. Scales were collected every 3 to 6 months. We evaluated the association of baseline ROADS and ΔROADS with survival using Cox regression analyses. Linear mixed effects models were used to assess changes over time in ROADS and ALSFRS-R. <b>Results:</b> Multivariate Cox models confirmed that baseline ROADS positively correlated with ALS survival (HR = 0.95, <i>p</i> < 0.001), while baseline ΔROADS negatively correlated with survival (HR = 1.26, <i>p</i> < 0.001). Additionally, linear mixed effects models suggested that ROADS, similar to ALSFRS-R, declined significantly over time, but there was no significant difference between these two. <b>Conclusions:</b> Our study indicates that Chinese ROADS is strongly related to ALS survival. Changes in ROADS with disease progression are similar to those in ALSFRS-R. These findings support Chinese ROADS as a reliable outcome measure for clinical trials, potentially enhancing the dimension of evaluating treatment effectiveness in ALS trials.https://www.mdpi.com/2227-9059/13/1/178amyotrophic lateral sclerosisscaledisease progressionoutcome measure |
| spellingShingle | Can Sun Yong Chen Lu Xu Wenjing Wang Nan Zhang Christina N. Fournier Nan Li Dongsheng Fan Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression Biomedicines amyotrophic lateral sclerosis scale disease progression outcome measure |
| title | Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression |
| title_full | Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression |
| title_fullStr | Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression |
| title_full_unstemmed | Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression |
| title_short | Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale as a Novel Tool to Measure Disease Progression |
| title_sort | rasch built overall amyotrophic lateral sclerosis disability scale as a novel tool to measure disease progression |
| topic | amyotrophic lateral sclerosis scale disease progression outcome measure |
| url | https://www.mdpi.com/2227-9059/13/1/178 |
| work_keys_str_mv | AT cansun raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT yongchen raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT luxu raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT wenjingwang raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT nanzhang raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT christinanfournier raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT nanli raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression AT dongshengfan raschbuiltoverallamyotrophiclateralsclerosisdisabilityscaleasanoveltooltomeasurediseaseprogression |